Drugs / Inactivated Influenza Vaccine
Inactivated Influenza Vaccine
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00091702 | ? → Jan 2006 | HIV infectious disease, influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00741039 | Aug 2008 → Aug 2012 | breast cancer, lung cancer, prostate cancer | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
| Phase 44 trials · 1 met primary | ||||||
| Phase 4 | NCT04998344 | Apr 2021 → Dec 2024 | influenza | University of Bergen | Unknown | No outcome recorded |
| Phase 4 | NCT03315975 | Oct 2017 → Jul 2026 overdue | viral infectious disease | University of Pennsylvania | Active not recruiting | No outcome recorded |
| Phase 4 | NCT00888381 | May 2009 | influenza | Seqirus | Completed | No outcome recorded |
| Phase 4 | NCT00138294 | Oct 1998 → Jun 2010 | influenza | Baylor College of Medicine | Completed | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT01568788 | Dec 2008 → Jan 2009 | influenza | Hualan Biological Engineering, Inc. | Completed | No outcome recorded |
| Comparator or background therapy9 trials | ||||||
| Phase 1 | NCT02500680 Comparator | Jul 2015 → Dec 2020 | influenza | Nova Immunotherapeutics Limited | Unknown | No outcome recorded |
| Phase 1 | NCT00906750 Comparator | Oct 2008 → Jul 2011 | cancer | St. Jude Children's Research Hospital | Completed | No outcome recorded |
| Phase 2 | NCT05606965 Comparator | Nov 2022 → Nov 2025 | influenza | ModernaTX, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT02285998 Comparator | Oct 2014 → May 2015 | influenza | Protein Sciences Corporation | Completed | Met primary |
| Phase 3 | NCT01554826 Comparator | Mar → May 2009 | influenza | Hualan Biological Engineering, Inc. | Completed | No outcome recorded |
| Phase 4 | NCT07177417 Comparator | Sep 2025 → Sep 2026 overdue | — | Washington University School of Medicine | Recruiting | No outcome recorded |
| Phase 4 | NCT03101462 Comparator | Feb → May 2011 | influenza | St. Louis University | Completed | No outcome recorded |
| Phase 4 | NCT01194297 Comparator | Aug 2010 → May 2012 | influenza | University of Rochester | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT00792051 Comparator | Sep 2008 → Dec 2010 | influenza | The University of Hong Kong | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 20 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00138294 ↗ |
| Known as | Fluzone HD | “IIV, Fluzone HD 60 µg per HA” PMID 35125224 ↗ Feb 2022 |
| Known as | Fluzone SD | “standard dose IIV (Fluzone SD, 15 µg per HA)” PMID 35125219 ↗ Feb 2022 |
| Known as | IAIV | “The current standard of care for HIV infected children is vaccination with an inactivated influenza vaccine (IAIV).” NCT00091702 ↗ |
| Known as | IIV | “Live Attenuated Influenza Vaccine (LAIV) and Inactivated Influenza Vaccine (IIV) were administered to eligible children through a research program to improve vaccination...” NCT00138294 ↗ |
| Known as | IIV4 | “This trial compared the protective efficacy in older adults of a quadrivalent, recombinant influenza vaccine (RIV4) with a standard-dose, egg-grown, quadrivalent, inactivated...” PMID 28636855 ↗ Jun 2017 |
| Known as | TIV | “One child aged 6-17 years in each of 796 households was randomized to receive 2009-2010 seasonal trivalent inactivated influenza vaccine (TIV) or saline placebo between August...” PMID 22670050 ↗ Jun 2012 |
| Modality | Vaccine | “The current standard of care for HIV infected children is vaccination with an inactivated influenza vaccine (IAIV).” NCT00091702 ↗ |
| Route | Intramuscular | “or 0.5 ml intramuscularly” NCT00138294 ↗ |